Research Spotlight: Research Opportunities in the Treatment of Mitral Valve Prolapse
The workshop outlined research opportunities to identify and treat patients with mitral valve prolapse (MVP) who are at risk of sudden cardiac arrest and death.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Department of Medicine
Contact Information
101 Merrimac Street
Boston,
MA
02114
Phone: 617-726-4321
Fax: 617-726-4213
Email: jlniles@partners.org
We have shown that antibodies to proteinase 3 and myeloperoxidase are highly specific markers for the spectrum of vasculitis that includes Wegener's Granulomatosis, microscopic polyarteritis (polyangiitis), Churg-Strauss syndrome and pauci-immune necrotizing and crescentic glomerulonephritis with or without lung hemorrhage. By reviewing large numbers of patients and testing large control groups, we have determined the diagnostic value of these tests in a variety of clinical situations. Currently, we are working to further define the role of tests for ANCA and anti-glomerular basement membrane antibodies in the evaluation of pulmonary hemorrhage syndrome.
Another focus of our work is to define the value of serial tests for ANCA in the long term management of patients with the above spectrum of diseases. These patients require long term treatment with immunosuppression. Balancing the treatment between over immunosuppression and recurrence of disease has been a major clinical challenge. ANCA appear to be a highly useful tool in the management of these patients.
In addition to research regarding ANCA associated disease, I run a clinical practice that routinely sees patients with ANCA disease 3 days a week and provides coverage for these patients on a 24 hour per day, 7 day a week basis.
Every day, our clinicians and scientists chart new terrain in biomedical research to treat and prevent human disease and advance patient care.
Your support of Nephrology helps us provide the best possible care today and expand what will be possible tomorrow.
We offer innovative, high-quality medical care, trains future medical leaders, and produces research that advances science and improves care.
The workshop outlined research opportunities to identify and treat patients with mitral valve prolapse (MVP) who are at risk of sudden cardiac arrest and death.
Clarivate Analytics’ Highly Cited Researchers List is an annual report of individuals who demonstrate a significant and broad influence in their field or fields of research.
Study reveals less severity of Omicron BA.2, with fewer deaths and lower likelihood of hospitalizations and invasive procedures.
Researchers looked at the impact of bacterial metabolism of host-produced bile acid (BA) metabolites on epithelial barrier integrity.
The wrist-worn devices may identify patients who would benefit from stroke prevention therapies.
Hydroxychloroquine dosing under 5 mg/kg/day is less effective in preventing lupus flares than higher dosing.
The Division of Nephrology at Massachusetts General Hospital is a leading provider of services for patients with kidney disease, including diagnosis and management of kidney diseases and medical management of renal transplantation.